Jeff Cummings, MD, ScD; Carolyn Clevenger, DNP, RN, GNP-BC, FAANP, FGSA, FAAN; Tatyana Gurvich, PharmD, BCGP; Lakelyn Hogan Eichenberger, PhD, MA, MBA; W. Clay Jackson, MD, DipTh; Sean Tunis, MD, MSc; Kate Zhong, MD, MSc, FRCP
Agitation in Alzheimer’s dementia is a serious neuropsychiatric condition that is highly prevalent and underdiagnosed. It contributes to adverse clinical outcomes for people living with Alzheimer’s dementia...
Michelle Puchowicz, PhD, from the University of Tennessee, writes about how ketones or ketosis is induced by diet, how it might be neuroprotective, and the steps needed to know for sure.
In this commentary, Joe McSherry, MD, PhD, discusses the safety and effectiveness of cannabinoids as alternative treatment options, despite widespread controversy.
New research examined whether preinjury, demographic, and family factors influence vulnerability to post-concussion symptoms persisting the year after mild traumatic brain injury.
In this commentary, Dr Rebecca Gottesman reviews the results of her ARIC-PET amyloid imaging study and explains what they mean for the future of clinical practice.
